Effects of Adding Linagliptin to Basal Insulin Regimen for Inadequately Controlled Type 2 Diabetes: A ≥52-week randomized, double-blind study

OBJECTIVE: To evaluate the efficacy and long-term safety of linagliptin added to basal insulins in type 2 diabetes inadequately controlled on basal insulin with or without oral agents. RESEARCH DESIGN AND METHODS: A total of 1,261 patients (HbA(1c) ≥7.0% [53 mmol/mol] to ≤10.0% [86 mmol/mol]) on bas...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Yki-Järvinen, Hannele, Rosenstock, Julio, Durán-Garcia, Santiago, Pinnetti, Sabine, Bhattacharya, Sudipta, Thiemann, Sandra, Patel, Sanjay, Woerle, Hans-Juergen
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Diabetes Association 2013
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3836100/
https://ncbi.nlm.nih.gov/pubmed/24062327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2718
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items